 Home > Medical News > Latest Medical News > Brief analysis of centralized collection varieties: meropenem.

Brief analysis of centralized collection varieties: meropenem.

 Last Update: 2022-04-16
 Source: Internet
 Author: User

Tags

hctz generic name

drug addiction articles

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

1.
Product Information

Drug name: Meropenem for injection

Specifications: 0.

25g; 0.

Instructions for indications:

For infections in adults and children caused by a single or multiple meropenem-susceptible bacteria:

Pneumonia (including hospital-acquired pneumonia), urinary tract infections, gynecological infections (eg, endometritis and pelvic inflammatory disease), skin and soft tissue infections, meningitis, sepsis
.

Empirical treatment.
For adult patients with neutropenia and fever, this product can be used alone or in combination with antiviral or antifungal drugs
.

Meropenem can be used alone or in combination with other antimicrobial agents to treat multiple infections
.

admission to market:

Drug Name	medical insurance	Essential medicine
Meropenem for Injection	Second	no

2.
Collecting information

episode batch	Drug name
Guo Cai seven	Meropenem for Injection

Market sales

Sales in the past four years:

Enterprise market share in 2021

4.
Market competition

The listing and evaluation of the same variety:

The number of critical articles: 18

Total number of production approvals: 20+

manufacturer	Specification	Overrated
Sumitomo Dainippon Pharma Co. ,Ltd.	0. 5g	original research
Shenzhen Haibin Pharmaceutical Co. , Ltd.	0. 25g	Yes
0. 5g	Yes
Hanhui Pharmaceutical Co. , Ltd.	0. 5g	Yes
0. 25g	Yes
CSPC Ouyi Pharmaceutical Co. , Ltd.	0. 5g	Yes
Shenzhen Haibin Pharmaceutical Co. , Ltd.	1g	Yes
Shenzhen Huayao Nanfang Pharmaceutical Co. , Ltd.	0. 25g	Yes
0. 5g	Yes
CSPC Ouyi Pharmaceutical Co. , Ltd.	1g	Yes
Chongqing Shenghuaxi Pharmaceutical Co. , Ltd.	0. 5g	Yes
0. 25g	Yes
Shandong Luoxin Pharmaceutical Group Co. , Ltd.	0. 25g	Yes
0. 5g	Yes
Peking University Pharmaceutical Co. , Ltd.	0. 5g	Yes
0. 25g	Yes
CSPC Ouyi Pharmaceutical Co. , Ltd.	0. 25g	Yes
Shenzhen Huayao Nanfang Pharmaceutical Co. , Ltd.	1g	Yes

New listing application

enterprise	Acceptance number	Date
Fuan Pharmaceutical Group Qingyutang Pharmaceutical Co. , Ltd.	CYHS2101872	2021-10-19
CYHS2101871	2021-10-19
Qilu Anti Pharmaceutical Co. , Ltd.	CYHS2101557	2021-08-11
CYHS2101556	2021-08-11
CYHS2101555	2021-08-11

Note: The above data is updated as of March 21, 2022

Similar related species

Classification	Drug Name
carbapenems	Ertapenem; Biapenem; Imipenem Cilastatin;
multidrug-resistant infection	Norvancomycin; Tigecycline; Polymyxin E

Comments

Super heavy-duty varieties, it turns out that players have all got on the car, and there are many competitions, and big price cuts are inevitable
.

Related Reading:

Brief analysis of centralized collection varieties: Milrinone
.

The market is not big, there are many snatchers

Brief analysis of centralized collection varieties: Terbutaline inhalation
.

Don't miss out

Brief analysis of centralized collection varieties: metformin vildagliptin
.

Come early and come early

Brief analysis of centralized collection varieties: calcium acetate
.

There is no price, the market is difficult to guarantee

Brief analysis of the collection varieties: methylprednisolone injection
.

Old varieties, import substitution still relies on centralized procurement to help

Brief Analysis of Collected Varieties: Caffeine Citrate Injection

Brief Analysis of Collected Varieties: Oseltamivir

Brief analysis of centralized collection varieties: tenofovir alafenamide

Brief Analysis of Collected Varieties: Sorafenib

Brief analysis of centralized collection varieties: lenvatinib

Brief analysis of centralized collection varieties: afatinib

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.